NattoPharma

Board of Directors

Frode Marc Bohan

Chairman of the Board

Mr. Bohan started his career within the industry in 1991 and founded the original NattoPharma Ltd (later NattoPharma ASA) in 2004, where he has been a significant shareholder from the incorporation. After two decades-long track record of founding and establishing prosperous companies, Mr. Bohan serves now as the Executive Chairman of NattoPharma. Mr. Bohan has studied marketing and computer science and based on the experience from building the MenaQ7 brand, he founded NoLabel and NutriCon, which are the world leading nutraceutical and pharmaceutical communications companies. Moreover, Mr. Bohan is a substantial Shareholder of Eqology ASA, and the chairman of the Board of directors at ImmunoPharma AS.

Christopher von Schirach-Szmigiel

Member of the Board

Christopher von Schirach-Szmigiel is educated within finance and management and has held postions as visiting professor in finance, management and strategic management and leadership among other places at New York University, Stockholm School of Economics, Norges Handelshøyskole, Bergen, Norway and the Pennsylvania State University. He was Board Director in Uniliver Nordic, Stora Data, Ericsson Group, Audi-Volkswagen Scandinavia and Porsche.  He has also served as Board dierector at Universities in Sweden, USA and Poland and has been expert and advisor for the Swedish government in shipping and shipbuilding.

Katarzyna Maresz

Member of the Board

A master’s graduate at the Jagiellonian University, Pharmacy Faculty (specialization: Medical Analytics, 1998). Holds a PhD in Biological Sciences at the Medical Faculty of the Jagiellonian University (2002). Held her practice at the Laboratory of Cellular and Molecular Immunology, Blood Research Institute, in Milwaukee, WI, USA (2003-2006). She is a post-doctoral fellow within the Marie-Curie Programme at the Department of Microbiology. Currently she is a scientific staff member at the Department of Biochemistry, Biophysics and Biotechnology at the Jagiellonian University as a part of a research project financed by the European Union.

Annette Elmqvist

Member of the Board

Annette Elmqvist

Annette Elmqvist, Pharmacist from Uppsala University. Started her career at the Medical Product agency and over 20 years within former Pharmacia as Qualified person/Production manager, Director of Operation at SBL vaccine and CEO at Unitech Biopharma. Current position is VP Quality Assurance at Scandinavian Biopharma AB. The broad experience within pharmaceutical industry especially within quality and production processes give her the mission to support companies to develop new products.

Stefan Hallden

Member of the Board

Stefan Hallden

Mr. Halldén is today working chairman of Life Science Sweden AB, a long time shareholder in NattoPharma and a valuable contributor to the development of the company. The last year he also held the position as a member of the Election Committee. Halldén has a long track record from international finance.

Nomination committee

The nomination committee, which is established by the ordinary general meeting held June 22nd 2007, serves for a period of two years. According to the Articles of Association, clause 3, the nomination committee can consist of up to three members. As per the general meeting held May 20th 2016, the nomination committee consists of the following members:

  • Frank Erikstad Bjordal, Chairman
  • Kim Øien, member

Contact Us

NattoPharma ASA
(head office)
Lilleakerveien 2B
0283 Oslo, Norway
info@nattopharma.com
Tel: (+47) 40 00 90 08

NattoPharma USA, Inc.
(North American Subsidiary)
328 Amboy Avenue, Ste. D
Metuchen, NJ 08840, USA
info.US@nattopharma.com
Tel: (+1) 609-454-2992

NattoPharma contact information:
Main office: Lilleakerveien 2B, 0283 Oslo,Norway
North American Subsidary: 328 Amboy Ave.,Ste. D,Metuchen, NJ 08840
Tel: (+47) 40 00 90 08
Tel: (+1) 609-454-2992
E-mail: info@nattopharma.com
E-mail: info.US@nattopharma.com
Created by:
Nutricon logo.
Search term:
Newsletter